GlucoTab® enables the digital planning, implementation and documentation of all ward-specific workflow steps necessary for managing blood sugar.

Doctors and nurses receive all relevant information for specific contexts. Workflow is additionally supported by a reminder feature. GlucoTab® facilitates the comprehensive digital representation of blood glucose management and relieves staff from administrative tasks.

GlucoTab therapy algorithms for insulin therapy

The automated insulin dosage suggestions for long-acting and short-acting insulin and the sequence of tasks for nurses and physicians are based on one of two rule-based algorithms. The structured process and insulin dosing support have been successfully evaluated and optimized in clinical trials.

The initial prescription of the therapy requires the selection of a therapy regimen appropriate for the patient and is therefore carried out by a physician. Basal-Bolus Insulin Therapy and Basal Insulin (BOT/BIT) Therapy are available with algorithm support. All further steps can be carried out by the nursing staff (configurable through user roles).

At therapy start GlucoTab suggests a safe starting dose.
Alternatively, the starting dose can be freely specified by the physician if there are already indications of insulin requirement from the pre-therapy.

The individual insulin administrations are performed by the nursing staff.

The dose calculation takes into account the current blood glucose level and meal as well as insulin “on board” still active in the body from previous insulin administrations, so that consultation with a doctor is normally not necessary.

Through the dosage suggestions at the regular adjustment of the daily insulin dose, a gradual and safe approximation to the blood glucose target range is achieved.

With GlucoTab support, also nursing staff can be granted permission to adjust the therapy, because a prescribed scheme is followed. The system automatically detects unsafe situations and ensures a check by a doctor.

Missing values or retrospective corrections are flexibly taken into account, unsafe situations are identified and a doctor’s review of the therapy is ensured.

GlucoTab Basal-Bolus Insulin Therapy

GlucoTab Basal Insulin Therapy

What does the therapy consist of?

  • long acting insulin once daily
  • short acting insulin with each meal and to correct high BG values
  • combination with certain oral antidiabetics or incretins possible

  • mainly long-acting insulin once daily
  • in combination with oral antidiabetic drugs and incretins
  • optional addition of short-acting insulin in the morning or with the largest meal of the day, if the daily basal insulin in combination with the prescribed other blood glucose-lowering drugs cannot prevent an increase in blood sugar during the day: “basal insulin plus” therapy

Initial daily insulin dose suggestion

is calculated based on age, body weight and kidney function

is calculated based on age and body weight

Frequency of blood glucose measurements and insulin administrations

Blood glucose measurements as well as insulin administrations are done daily at mealtimes or before going to bed.
The intensity of the therapy is always the same.

Initially, to find or, if necessary, adjust the therapy, measurements are taken in the morning, at noon and in the evening.
If the course of therapy is stable, it is suggested that only fasting blood glucose values be measured in the morning.
If the therapy is stable, the intensity of the measurements is reduced.

Time of basal insulin administration

Basal insulin administration at lunchtime has proven to be effective in an inpatient setting; administration in the evening or before going to bed can also be prescribed.

Basal insulin can be prescribed in the morning (recommended in geriatric settings), in the evening or before going to bed.

Adjustment of the therapy / the planned dose for the day

The daily insulin dose is adjusted daily.
The distribution of short-acting insulin between the times of day is handled automatically.

The basal insulin dose is not always adjusted on a daily basis, but depends, among other things, on the health status of the patient and the availability of the necessary blood sugar levels.

Blood glucose target range

The target range of 100-140 mg/dl (5.6-7.8 mmol/l) before meals is recommended to achieve a reduction of complications in the inpatient setting.

The blood glucose target range and the tolerated increase in blood glucose during the day are set according to the patient’s health status, in order to give special consideration to geriatric patients.

Custom therapy with GlucoTab as a general electronic medication solution for diabetes

GlucoTab supports the collaborative process in the hospital with prescription by doctors and execution by nursing staff for all forms of therapy. Open tasks are displayed for both occupational groups.

Dosage with undetermined dose: What is often indicated on paper as a “tub” ˽ is referred to in GlucoTab as X-dose:

  • Administration of the drug is planned in the time of day, however the dose can only determined when a blood sugar value is available in the time of day.
  • Open tasks show who has to do what and when. Blood glucose measurement (care) → determine dose (doctor) → medication administration (care).
  • Alternatively, the dose can be ordered verbally by the physician and recorded by the nurse.

Patient self-management can be indicated when prescribing the therapy. Insulin prescriptions are then initialized with an undetermined dose (X) because the dose is determined by the patient himself. Documentation of blood glucose measurements and medication administrations performed by the patient is retrospectively possible.

If necessary (e.g. gestational diabetes), ordering postprandial blood glucose measurements is possible and is supported by the automatic generation of tasks for timely post-meal measurement.